Related references
Note: Only part of the references are listed.Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies
Maria Xilouri et al.
MOVEMENT DISORDERS (2016)
Inhibition of Light Chain 6aJL2-R24G Amyloid Fiber Formation Associated with Light Chain Amyloidosis
Angel E. Pelaez-Aguilar et al.
BIOCHEMISTRY (2015)
Transient β-hairpin formation in α-synuclein monomer revealed by coarse-grained molecular dynamics simulation
Hang Yu et al.
JOURNAL OF CHEMICAL PHYSICS (2015)
Exploring the Influence of EGCG on the β-Sheet-Rich Oligomers of Human Islet Amyloid Polypeptide (hIAPP1-37) and Identifying Its Possible Binding Sites from Molecular Dynamics Simulation
Qianqian Wang et al.
PLOS ONE (2014)
Toward the Molecular Mechanism(s) by Which EGCG Treatment Remodels Mature Amyloid Fibrils
Fernando L. Palhano et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
MODULATORS OF AMYLOID PROTEIN AGGREGATION AND TOXICITY: EGCG AND CLR01
Aida Attar et al.
TRANSLATIONAL NEUROSCIENCE (2013)
Molecular Rotors: What Lies Behind the High Sensitivity of the Thioflavin-T Fluorescent Marker
Nadav Amdursky et al.
ACCOUNTS OF CHEMICAL RESEARCH (2012)
Comparison of Three Amyloid Assembly Inhibitors: The Sugar scyllo-Inositol, the Polyphenol Epigallocatechin Gallate, and the Molecular Tweezer CLR01
Sharmistha Sinha et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Analysis of the Inhibition and Remodeling of Islet Amyloid Polypeptide Amyloid Fibers by Flavanols
Ping Cao et al.
BIOCHEMISTRY (2012)
Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils
Jan Bieschke et al.
NATURE CHEMICAL BIOLOGY (2012)
Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons
Martin Lundblad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications
Brahma N. Singh et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Tetrahydroxystilbene glucoside protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity
Fang-ling Sun et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds
Mario Caruana et al.
FEBS LETTERS (2011)
Aromatic Small Molecules Remodel Toxic Soluble Oligomers of Amyloid β through Three Independent Pathways
Ali Reza A. Ladiwala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
Laura A. Volpicelli-Daley et al.
NEURON (2011)
The History of Parkinson's Disease: Early Clinical Descriptions and Neurological Therapies
Christopher G. Goetz
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
alpha-Synuclein: Membrane Interactions and Toxicity in Parkinson's Disease
Pavan K. Auluck et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 26 (2010)
The Flavanol (-)-Epigallocatechin 3-Gallate Inhibits Amyloid Formation by Islet Amyloid Polypeptide, Disaggregates Amyloid Fibrils, and Protects Cultured Cells against IAPP-Induced Toxicity
Fanling Meng et al.
BIOCHEMISTRY (2010)
Mitochondrial dysfunction in Parkinson's disease
Konstanze F. Winklhofer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Membrane Interactions of Oligomeric Alpha-Synuclein: Potential Role in Parkinsons Disease
Bart D. van Rooijen et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2010)
Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Aβ into Off-pathway Conformers
Ali Reza A. Ladiwala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Metals, oxidative stress and neurodegenerative disorders
Klaudia Jomova et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Membrane Permeabilization by Oligomeric α-Synuclein: In Search of the Mechanism
Bart D. van Rooijen et al.
PLOS ONE (2010)
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Jan Bieschke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
(-)-Epigallocatechin-3-Gallate (EGCG) Maintains κ-Casein in Its Pre-Fibrillar State without Redirecting Its Aggregation Pathway
Sean A. Hudson et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
α-Synuclein and neuronal cell death
Mark R. Cookson
MOLECULAR NEURODEGENERATION (2009)
Epigallocatechin gallate (EGCG) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and GSK3 beta activation
Chih-Li Lin et al.
NEUROBIOLOGY OF AGING (2009)
Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy
Qian Yang et al.
SCIENCE (2009)
Neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) on paraquat-induced apoptosis in PC12 cells
Rong-Rong Hou et al.
CELL BIOLOGY INTERNATIONAL (2008)
Small-molecule aggregates inhibit amyloid polymerization
Brian Y. Feng et al.
NATURE CHEMICAL BIOLOGY (2008)
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Jia-Yi Li et al.
NATURE MEDICINE (2008)
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E. Ehrnhoefer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Aggregated α-synuclein mediates dopaminergic neurotoxicity in vivo
Magali Periquet et al.
JOURNAL OF NEUROSCIENCE (2007)
Epigallocatechin gallate inhibits nitric oxide-induced apoptosis in rat PC12 cells
Ji Yeon Jung et al.
NEUROSCIENCE LETTERS (2007)
The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions
Stephen Tam et al.
NATURE CELL BIOLOGY (2006)
Cytosolic catechols inhibit α-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates
Joseph R. Mazzulli et al.
JOURNAL OF NEUROSCIENCE (2006)
Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities
James Shorter et al.
MOLECULAR CELL (2006)
Selective loss of dopaminergic neurons and formation of Lewy body-like aggregations in α-synuclein transgenic fly neuronal cultures
Soon S. Park et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Mapping long-range interactions in α-synuclein using spin-label NMR and ensemble molecular dynamics simulations
MM Dedmon et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases
O Weinreb et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2004)
α-synuclein produces a long-lasting increase in neurotransmitter release
SM Liu et al.
EMBO JOURNAL (2004)
A protein-chameleon:: Conformational plasticity of α-synuclein, a disordered protein involved in neurodegenerative disorders
VN Uversky
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2003)
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service
AJ Hughes et al.
BRAIN (2002)
Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster
RG Pendleton et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein -: A possible molecular link between Parkinson's disease and heavy metal exposure
VN Uversky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Effects of pH and metal ions on antioxidative activities of catechins
M Kumamoto et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2001)
Hsp70 and Hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils
PJ Muchowski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Review: History of the amyloid fibril
JD Sipe et al.
JOURNAL OF STRUCTURAL BIOLOGY (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
KA Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)